Is immunohistochemistry more sensitive than hematoxylin-eosin staining for identifying perineural or lymphovascular invasion in oral squamous cell carcinoma? A systematic review and meta-analysis

Background: This study aimed to analyze whether immunohistochemistry (IHC) is more sensitive than hematoxylin-eosin (H&E) staining for identifying perineural invasion (PNI) or lymphovascular invasion (LVI) in oral squamous cell carcinoma (OSCC). Material and Methods: In this systematic review and meta-analysis (Prospective Register of Systematic Reviews – CRD 42021256515), data were obtained from six databases (PubMed, Scopus, LILACS, Web of Science, EBSCO, LIVIVO, Embase) and the grey literature. Cross-sectional observational studies of the diagnostic sensitivity of IHC for PNI and LVI were included. Studies were selected in two phases: first collection and reference retrieval. The Quality Assessment of Diagnostic Accuracy Studies-2 tool assessed study quality, while the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach assessed evidence quality. The meta-analysis (random effects model) was performed using MedCalc 18.2.1 software (MedCalc®) (p<0.05). Results: Four studies (560 patients with 295 biopsies) were analyzed. The combined sensitivity was 76% (95% confidence interval [CI], 44.30–97.19%) and specificity was 42% (95% CI, 23.40–62.02%). The positive predictive value (PPV) and negative predictive value (NPV) were 61% (95% CI, 49.78–71.53%) and 70% (95% CI, 37.63–94.43%). The overall accuracy was 58% (95% CI, 45.17–70.65%). The risk of bias was low, and GRADE analysis showed a very low certainty of evidence. Conclusions: Our data suggest that IHC staining to highlight PNI/LVI may be useful in cases in which H&E analysis results in a negative decrease in the prevalence of false-negative cases and underestimated treatment.(AU)

Fixation of free gingival grafts with cyanoacrylate glues: A histomorphometric and immunohistochemical study.

AIM: The objective of this study was to evaluate the inflammatory process resulting from the use of two cyanoacrylate-based adhesives to stabilize grafts. METHODOLOGY: A total of 45 male Wistar rats were randomly divided into three groups (n = 15/group) treated with ethyl cyanoacrylate glue (TG1), octyl-2-cyanoacrylate glue (TG2) or suture threads (CG). After de-epithelialization in the anterior gingival region of the mandible, the graft was removed from the donor site (hard palate), taken to the recipient site and stabilized according to the protocol of each group. After 7, 14, and 45 days, the animals were euthanized. The graft area was analysed macroscopically, histologically, histochemically (Masson trichrome), and immunohistochemically positive cell count for TGF-ß, α-SMA, RANKL, OPG, FGF, and IL-10. The Kruskal-Wallis/Dunn test (SPSS 20.0, p < 0.05) was used for analysis. RESULTS: There was no difference in the clinical parameters among the three groups, but TG1 showed the lowest mononuclear inflammatory cell count and the highest amount of total collagen. FGF immunoexpression was significantly higher for the CG group, but the TG2 showed a significant reduction in the RANKL/OPG ratio. CONCLUSION: TG1 had a mild inflammatory response and a higher collagen deposition than other glues, and TG2 had a reduction in the RANKL / OPG ratio.

Peptídeos antimicrobianos como terapia complementar periodontal: uma análise da literatura / Antimicrobial peptides as periodontal complementary therapy: an analysis of literature

Objetivo: realizar um levantamento sistemático da literatura no que tange ao uso de peptídeos antimicrobianos contra periodontopatógenos e indicar quais os peptídeos e micro-organismos mais estudados, com o objetivo final de traçar um perfil das publicações na área. Material e métodos: a busca por artigos ocorreu na base de dados Pubmed, com os seguintes critérios de inclusão: publicação nos últimos dez anos; palavras-chave "Antimicrobial Peptide" and "Periodontal" and "Bacteria", publicados em inglês e disponíveis gratuitamente na íntegra para leitura. Um total de dez artigos foram selecionados após o refinamento dos dados. Resultados: apesar do pequeno número de estudos encontrados, evidencia-se o potencial uso de peptídeos antimicrobianos no controle das principais bactérias periodontopatogênicas. Além disso, os peptídeos produzidos por células da mucosa oral (Defensinas, LL-37 e Histatinas), bem como os micro-organismos Porphyromonas gingivalis e Fusobacterium nucleatum, foram os mais estudados. Conclusão: é possível concluir que o uso de peptídeos antimicrobianos como potencial ferramenta no controle microbiano tem uma importância crescente, provavelmente devido à sua ampla aplicabilidade, mecanismos de ação e baixos índices de resistência. Contudo, estudos relacionados à sua toxicidade sobre células humanas, modo de aplicação e ensaios clínicos precisam ser realizados.

Objectives: to perform a systematic review of the literature regarding the use of antimicrobial peptides against periodontopathogens and indicate the most studied peptides and microorganisms, with the final objective of outlining a profile of publications in the area. Material and methods: the search for articles occurred in Pubmed database with the following inclusion criteria: publication in the last 10 years; Keywords "Antimicrobial Peptide" and "Periodontal" and "Bacteria", published in English and freely available for reading. Results: a total of 10 articles were selected after refi ning the data. Despite the small number of studies found, it is evident the potential use of antimicrobial peptides in the control of the main periodontopathogenic bacteria. In addition, the peptides produced by oral mucosa cells (Defensins, LL-37 and Histatins) as well as the microorganisms Porphyromonas gingivalis and Fusobacterium nucleatum were the most studied. Conclusion: it is possible to conclude that the use of antimicrobial peptides as a tool in microbial control is of increasing importance, probably due to their wide applicability, mechanisms of action and low resistance indices. However, studies related to its toxicity on human cells, mode of application and clinical trials still need to be performed.